Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
   L01 ANTINEOPLASTIC AGENTS
     L01A ALKYLATING AGENTS
     L01B ANTIMETABOLITES
     L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
     L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
     L01X OTHER ANTINEOPLASTIC AGENTS
       L01XA Platinum compounds
       L01XB Methylhydrazines
       L01XC Monoclonal antibodies
       L01XD Sensitizers used in photodynamic/radiation therapy
         L01XD01 Porfimer sodium
         L01XD03 Methyl aminolevulinate [DG:DG00707]
         L01XD04 Aminolevulinic acid [DG:DG00708]
           D07567  Aminolevulinic acid
           D02908  Aminolevulinic acid hydrochloride (JAN/USAN) <JP/US>
         L01XD05 Temoporfin
         L01XD06 Efaproxiral [DG:DG00709]
         L01XD07 Padeliporfin
       L01XE Protein kinase inhibitors
       L01XX Other antineoplastic agents
       L01XY Combinations of antineoplastic agents
   L02 ENDOCRINE THERAPY
   L03 IMMUNOSTIMULANTS
   L04 IMMUNOSUPPRESSANTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: February 22, 2019
According to WHO's ATC 2019

» Japanese version